Home›Companies›Biotech & Pharma›Myodenovo

Myodenovo Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 16, 2023·Suggest an edit

About Myodenovo

Myodenovo is a private company based in Raleigh, North Carolina, incorporated in 2022 in Delaware. It has reported $105,000 raised in one offering on Form D since February 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 21, 2022Feb 16, 2023$105,000of $2.0M target2$52,500Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Myodenovo's Form D filed Feb 16, 2023.

GE
George Engelmayr
President, Secretary, Treasurer and Director

Sources

  1. SECMyodenovo Inc. filing history